Villa won the Europa League and will play in the Champions League next season, but due to the former, they could unlock a sixth Champions League place for the Premier League should they finish fifth.

Google didn't forget AI creators in its latest round of Gemini announcements as part of Google I/O. The company just officially revealed Gemini Omni, a new model that can "create anything from any ...

Arsenal can win Premier League title on Tuesday if Man City don't win at Bournemouth; Liverpool's place in the Champions League can be confirmed; Spurs can relegate West Ham; Watch Bournemouth vs Man ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Arsenal could be crowned as Premier League champions in under a week should results go their way. The Gunners sit two points clear of nearest rivals Manchester City, with Pep Guardiola’s men having ...

Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, ...

Finding and developing new molecules is one of the great research endeavors of modern chemistry. From the development of new drugs to the creation of more sustainable materials, everything depends on ...

If vanilla AI image generators leave you feeling underwhelmed, it's time to play with the spicy stuff. I put the most popular NSFW options to the test so you can find the one that really hits the mark ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...